Back around 20 years ago, women got a scare when they were told that hormone therapy could increase their risk of cancer. But it turns out the people who released that info were bureaucrats, not the scientists doing the study. They were half wrong — and it’s a major half.
It seems that — after a 20-year study of 160,000 women — there’s a very big difference depending on the type of hormone therapy.
Estrogen plus progestin therapy does seem to lead to an increased cancer risk, but estrogen-only therapy not only doesn’t have that cancer risk, but can reduce it as well as coronary heart disease.
In addition to its beneficial effects on menopause symptoms (which are widely acknowledged), the new study found that, after an average of